Skip to main content
Utility menu
Donate
Join
Member Login
Search
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Careers
Support The Mission
Support The Mission
Become a Member
Explore Different Ways to Give
Create a Legacy
Join IASLC's Partners for Thoracic Cancer Care
Recognizing Our Donors
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
WCLC 2024 Highlights
Access Online Learning
Conferences & Education
Conferences & Education
Conferences
Webinars
Online Learning: Lung Cancer 360
Lung Cancer Considered Podcast
WCLC 2024
Science & Research
Science & Research
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Scientific Projects
Scientific Projects
IASLC Staging Project: Lung Cancer, Thymic Tumors, and Mesothelioma
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Past IASLC Scientific Projects
Research Grant Program
Research Grant Program
Research Grant Recipients
IASLC Academy
Publications, Resources & Guidelines
Membership
Membership
Become a Member
Renew Your Membership
Early-Career Opportunities
Partners Society Membership Offers
Patients & Caregivers
Patients & Caregivers
STARS Training
Lung Cancer Awareness Month
News
News
IASLC Lung Cancer News
WCLC 2024 News
Press Releases
Search
Fulltext search
Fulltext search
Search
Displaying 25 - 36 items out of 360 results
ILCN article
Statistical Design Flexibility Versus Optimism: The Example of KEYNOTE-604
ILCN article
University of California, Davis, Thoracic Oncology Innovation Group to Again Host Latin American Oncologists for 3-Day Preceptorship
ILCN article
Cell-free RNA Affords Another Tool in Lung Cancer Diagnosis and Treatment Monitoring
ILCN article
Supporting the Detection of Early-Stage Disease with Use of Biomarkers
ILCN article
Leveraging ctDNA to Detect Minimal Residual Disease Following Surgery
ILCN article
ctDNA Offers a Window Into Emerging Mechanisms of Resistance to Targeted Therapy
ILCN article
Dr. Christian Rolfo Previews the New IASLC Consensus Statement on Liquid Biopsy
ILCN article
FDA Perspectives on the Use of Liquid Biopsy in NSCLC
ILCN article
Biopsy Options Create New Decision-making Points for Clinicians
ILCN article
The RAMES Study: A New Strategy of Targeting Angiogenesis in Mesothelioma
ILCN article
Elimination of Clinical Trial Disparities Requires a New Lens for Viewing Justice, New Approach to Patient’s Role
ILCN article
Immunotherapy, TKIs for Resectable/Resected NSCLC: Dr. Masahiro Tsuboi Provides a Comprehensive Overview of Promising Phase II Data, Phase III Status
Pagination
First
First page
‹
Previous page
1
2
3
4
5
6
7
8
9
…
›
Next page
Last
Last page